image/svg+xml

VISION

There are many intractable diseases in the world that have continuously contributed to the suffering of mankind and for which a therapeutic method for complete remission has yet to be established. In particular, overcoming “Cancer” is the most common subject of concern.

About us image
About us image
About us image

COMPANY INFO

Company name
Cell Therapy Technology Institution (Inc.)
English name
CyTIX, Inc.
Address
2 – 3 – 3 Shibakoen, Minato-ku, Tokyo 105-0011 JapanMap
Established
September 10, 2010
Capital
26.25 million yen
Management
Koichi Okubo, President & CEO
Accounting period
March
No. of employees
14
Business
Development of fusion cell vaccines and deployment technology Management support of fusion cellular treatment medical organization
Stock shares
Not listed
Telephone
03 – 5733 – 4662
FAX
03 – 5733 – 4663
URL
www.cytix.co.jp

BOARD OF DIRECTORS/MANAGEMENT

President & CEO

Koichi Okubo

Graduated from the Department of Economics, Hitotsubashi University. MBA at Southern California University (Masters in Management). Worked for Sumitomo Bank for 15 years (Resided in Hong Kong for 7 years), PWC Consulting, PCCW Japan, Caliber International, and was an independent International Business consultant. Appointed as Executive Director of the company in July 2011. Appointed as President & CEO in June 2016.

Director

Yoshihisa Ishiguro

Completed a Masters from the Graduate School (Electric Engineering) at Tokyo University and also a Masters in Engineering. Employed by the Ministry of International Trade and Industry. Also served as a room chief of Fine Ceramics of Life Industry and Commercial Engineering Director of Ministry of Tohoku Trading, and currently retired. President at Total Energy Supply Company (Marushin Co., Ltd.). Served as the President of Land Transportation Company (East and West Shipping Company), the President of Life Technology Institution, and visiting professor at Nagaoka Science Technology University and the Graduate School of Business Creation. After the Chugoku and Shin-etsu Great Earthquake, served as a committee chair of the Disaster Recovery Special Measurement Committee. Appointed to Board of Directors in September 2010.

Director

Haruki Shorinji

Graduated from the Department of Environmental Information, Keio University. Employed by CyTIX,Inc. in January 2016 and appointed to Board of Directors in June 2016.

ADVISORY BOARD

Tatsuya Ono, MD, Ph. D.

Graduated from the School of Medicine, Tokyo Jikeikai. Passed the Japanese National Examinations for Medical Practitioners. M.D. at the School of Medicine, Keio University. Professor at the Cancer Research Institute of Columbia University, Professor at the School of Medicine, Tokyo Jikeikai University, visiting Professor at Harbored University, First President of the DNA Medical Institute at Jikei University and Honorary Professor at Tokyo Jikeikai School of Medicine. Chairman of the Board of Directors of the Medical Corporation Jiyukai.

Ph. D.

Sadatoshi Sakuma

Graduated from Tohoku University, Faculty of Science. PhD at The University of Pennsylvania. Researcher at Wister Institute, The University of Pennsylvania, Biochemistry Assistant at McGill University, Researcher at the Endocrinology Institute, Hamburg University, School of Medicine, Director at Cellular Engineering Center of Meiji Milk Products Co., Ltd., President of Bio Venture Company (Cell Signals Co., Ltd.). Specialist in Biochemistry. Appointed as Executive Director of the company in September 2010. Appointed as the President & CEO from September 2011 through June 2016. Current chairman of the company.

Junichiro Fujimoto, MD, Ph. D.

Graduated from the School of Medicine, Gifu University. Passed the Japanese National Examinations for Medical Practitioners. Intern at Sapporo Medical School (Major in Pathology). Researcher at School of Medicine at Stanford University. Doctor of Medicine. Director of Clinical Studies and subsequently a special assistant to Chair of the Board of Directors at National Children’s Medical Research Center (Currently National Center for Child Health and Development). Board of Directors of the Medical Corporation Jiyukai. President of Acti-clinic.